Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Bachem Holding AG
  6. Summary
    BANB   CH1176493729

BACHEM HOLDING AG

(BANB)
  Report
End-of-day quote Swiss Exchange  -  2022-11-28
87.70 CHF   -3.94%
11/14Bachem Welcomes New Site Manager In Torrance : Luckner Ulysse
PU
11/07Bachem - What does it take to manufacture oligonucleotides
AQ
10/05Bachem expands presence in northwestern Switzerland, New production site planned in Sisslerfeld
AQ
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Days
:
Hours
:
Minutes
:
Seconds
Quotes 5-day view   End-of-day quote. End-of-day quote Swiss Exchange
11/23/2022 11/24/2022 11/25/2022 11/28/2022 11/29/2022 Date
88.8 90.25 91.5 91.3 87.7 Last
59172 47278 95734 88811 63249 Volume
+0.57% +1.63% +1.39% -0.22% -3.94% Change
Estimated financial data (e)
Sales 2022 547 M 575 M 575 M
Net income 2022 107 M 113 M 113 M
Net cash position 2022 109 M 115 M 115 M
P/E ratio 2022 59,6x
Yield 2022 0,84%
Sales 2023 620 M 652 M 652 M
Net income 2023 126 M 132 M 132 M
Net cash position 2023 79,3 M 83,3 M 83,3 M
P/E ratio 2023 50,0x
Yield 2023 0,92%
Capitalization 6 468 M 6 794 M 6 794 M
EV / Sales 2022 11,6x
EV / Sales 2023 10,3x
Nbr of Employees 1 663
Free-Float 86,0%
More Financials
Company
Bachem Holding AG is a Switzerland-based biochemical company that provides services to the pharmaceutical and biotechnology industry. The Company focuses on the process development and manufacturing of peptides and organic molecules as active pharmaceutical ingredients (APIs), as well as on the development of biochemical products for research purposes. Its product portfolio comprises fluorescent dyes for the... 
More about the company
Ratings of Bachem Holding AG
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B-
More Ratings
All news about BACHEM HOLDING AG
11/14Bachem Welcomes New Site Manager In : Luckner Ulysse
PU
11/07Bachem - What does it take to manufacture oligonucleotides
AQ
10/05Bachem expands presence in northwestern Switzerland, New production site planned in Sis..
AQ
10/05European shares retreat amid interest rate jitters, recession fears
RE
10/05Biotechnology Group Bachem To Buy New Site In Switzerland
MT
10/05Bachem : expands presence in northwestern Switzerland. New production site planned in Siss..
PU
09/21Bachem signs large volume contracts for peptides
AQ
09/20Global markets live: Apple, United Health, Ford, PepsiCo, Peloton...
MS
09/20Bachem group - ad hoc announcement pursuant to art. 53 lr of the swiss stock exchange s..
AQ
09/20European shares slide for sixth straight session amid central bank worries
RE
09/20European shares open higher on boost from banks
RE
09/20Bachem : Presentation Capital Markets Day 2022
PU
09/20Switzerland's Bachem Wins Large Supply Orders For Peptides
MT
09/19Bachem Holding AG(SWX:BANB) added to FTSE All-World Index
CI
09/12Bachem Holding AG Appoints Michael Staroverov as New Group Chief Information Officer
CI
More news
News in other languages on BACHEM HOLDING AG
11/21Aktien Schweiz Schluss: SMI dank Schwergewichten mit Gewinnen
11/10Aktien Schweiz Schluss: Kursfeuerwerk nach US-Daten - SMI über 11..
10/24Aktien Schweiz Schluss: SMI schliesst mit deutlichem Plus
10/19Aktien Schweiz Schluss: Schwächer - SMI schwenkt auf Konsolidieru..
10/19Aktien Schweiz: SMI ruht nach rasantem Anstieg aus
More news
ETFs positioned on BACHEM HOLDING AGETFs and Trackers with Trackinsight
ETF WeightVar. 5daysRatingGeography
UBS ETF (CH) - SMIM A-dis - CHF1.13%1.14%Switzerland
IShares SMIM (CH) - CHF1.12%1.33%Switzerland
UBS ETF (CH) - SPI Mid A-dis - CHF0.82%1.44%Switzerland
UBS ETF - MSCI Switzerland IMI Socially Res...0.48%0.91%-NC
UBS ETF (CH) MSCI Switzerland IMI Socially ...0.48%0.81%-NC
More ETFs positioned on BACHEM HOLDING AG
Chart BACHEM HOLDING AG
Duration : Period :
Bachem Holding AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BACHEM HOLDING AG
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 5
Last Close Price 87,70 CHF
Average target price 74,40 CHF
Spread / Average Target -15,2%
EPS Revisions
Managers and Directors
Thomas Meier Chief Executive Officer
Alain Schaffter Chief Financial Officer
Kuno Sommer Chairman
GŘnther Loidl Chief Technology Officer
Ralph Sch÷nleber Vice President-Research & Development
Sector and Competitors
1st jan.Capi. (M$)
BACHEM HOLDING AG-38.76%7 109
MODERNA, INC.-30.95%67 378
IQVIA HOLDINGS INC.-24.68%39 832
LONZA GROUP AG-34.32%39 180
ALNYLAM PHARMACEUTICALS, INC.20.76%25 738
SEAGEN INC.-24.08%22 506